Urine calcium and deoxypyridinoline in assessment of response to local radiation therapy for metastatic bone disease


TOPKAN E., KARAOĞLU A.

Journal of Experimental & Clinical Cancer Research, vol.26, no.4, pp.553-559, 2007 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 4
  • Publication Date: 2007
  • Journal Name: Journal of Experimental & Clinical Cancer Research
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.553-559
  • Keywords: urine calcium, deoxypyridinoline, palliative radiotherapy, PYRIDINIUM CROSS-LINKS, DOSE-RANGING TRIAL, BREAST-CANCER, BIOCHEMICAL MARKERS, PAMIDRONATE TREATMENT, DISODIUM PAMIDRONATE, MULTIPLE-MYELOMA, ZOLEDRONIC ACID, PHASE-I, RESORPTION
  • Dokuz Eylül University Affiliated: No

Abstract

To evaluate the predictability of urine calcium (Ca2+) and deoxypyridinoline (DPD) in the assessment of response to palliative radiation therapy (RT) for metastatic bone disease.